Company Filing History:
Years Active: 2024
Title: Dirk Hose: Innovator in Targeted Cancer Therapies
Introduction
Dirk Hose is a prominent inventor based in Pfaeffikon, Switzerland. He has made significant contributions to the field of targeted cancer therapies, particularly through his innovative work on bispecific antibodies.
Latest Patents
Dirk Hose holds a patent for "Bispecific GPC3xCD28 and GPC3xCD3 antibodies and their combination for targeted killing of GPC3 positive malignant cells." This invention relates to GPC3×CD3 bispecific antibodies and GPC3×CD28 bispecific antibodies, which are designed to target GPC3 positive malignancies. The bispecific antibodies are unique in that they do not compete for binding to GPC3, allowing for more effective treatment options.
Career Highlights
Dirk Hose is associated with Lamkap Bio Gamma AG, where he continues to advance his research and development efforts. His work focuses on creating innovative solutions for cancer treatment, leveraging his expertise in antibody technology.
Collaborations
Dirk collaborates with talented professionals in his field, including Eric Hatterer and Anja Seckinger. These collaborations enhance the research and development process, leading to more effective therapeutic solutions.
Conclusion
Dirk Hose is a key figure in the development of targeted cancer therapies, with a focus on bispecific antibodies. His innovative work and collaborations are paving the way for advancements in the treatment of GPC3 positive malignancies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.